Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Rituximab

5

XVII.a Respiratory tract infection incl. pneumonia

3
Last update : 18/09/2022
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anti-CD20 antibody therapy
4

Publications

Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort.
Clinical rheumatology 2022 Sep;41;2809-2816 2022 Sep
Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report.
Drug safety - case reports 2018 May 11;5;22 2018 May 11
Rituximab in severe, treatment-refractory interstitial lung disease.
Respirology (Carlton, Vic.) 2014 Apr;19;353-9 2014 Apr

Powered by

  • ^
  • Contact
  • Cookies
  • About